Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Armstrong

Showing results (961-970 of 1,035) with videos related to

Pageof 104
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2020
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote TrialCesar A Santa-Maria, Janelle W Coughlin, Dipali Sharma, et al.
JCO Precision Oncology|January 14, 2026
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i><sup><i>V600E</i></sup> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol HApril K S Salama, Victoria Wang, Erin R Macrae, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 12, 2026
Invasive in-utero cardiac intervention in the hydropic fetus may improve survival: results from the International Fetal Cardiac Intervention Registry (IFCIR)A J Moon-Grady, A Tulzer, A K Armstrong, et al.
Frontiers in Immunology|November 12, 2021
Human Complement C4B Allotypes and Deficiencies in Selected Cases With Autoimmune DiseasesDanlei Zhou, Michael Rudnicki, Gilbert T Chua, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 4, 2015
Inherited genetic variants associated with occurrence of multiple primary melanomaDavid C Gibbs, Irene Orlow, Peter A Kanetsky, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 3, 2018
Engineering Anisotropic Muscle Tissue using Acoustic Cell PatterningJames P K Armstrong, Jennifer L Puetzer, Andrea Serio, et al.
The Journal of Investigative Dermatology|May 13, 2018
Inherited Genetic Variants Associated with Melanoma BRAF/NRAS SubtypesNancy E Thomas, Sharon N Edmiston, Irene Orlow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 30, 2014
Sun exposure and melanoma survival: a GEM studyMarianne Berwick, Anne S Reiner, Susan Paine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 9, 2021
Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3Andrew R Clamp, Domenica Lorusso, Amit M Oza, et al.
Gynecologic Oncology|May 17, 2024
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparibJoyce F Liu, Niya Xiong, Robert M Wenham, et al.
Pageof 104

Showing results (961-970 of 1,035) with videos related to

Sort By:
Pageof 104
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2020
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote TrialCesar A Santa-Maria, Janelle W Coughlin, Dipali Sharma, et al.
JCO Precision Oncology|January 14, 2026
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i><sup><i>V600E</i></sup> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol HApril K S Salama, Victoria Wang, Erin R Macrae, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 12, 2026
Invasive in-utero cardiac intervention in the hydropic fetus may improve survival: results from the International Fetal Cardiac Intervention Registry (IFCIR)A J Moon-Grady, A Tulzer, A K Armstrong, et al.
Frontiers in Immunology|November 12, 2021
Human Complement C4B Allotypes and Deficiencies in Selected Cases With Autoimmune DiseasesDanlei Zhou, Michael Rudnicki, Gilbert T Chua, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 4, 2015
Inherited genetic variants associated with occurrence of multiple primary melanomaDavid C Gibbs, Irene Orlow, Peter A Kanetsky, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 3, 2018
Engineering Anisotropic Muscle Tissue using Acoustic Cell PatterningJames P K Armstrong, Jennifer L Puetzer, Andrea Serio, et al.
The Journal of Investigative Dermatology|May 13, 2018
Inherited Genetic Variants Associated with Melanoma BRAF/NRAS SubtypesNancy E Thomas, Sharon N Edmiston, Irene Orlow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 30, 2014
Sun exposure and melanoma survival: a GEM studyMarianne Berwick, Anne S Reiner, Susan Paine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 9, 2021
Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3Andrew R Clamp, Domenica Lorusso, Amit M Oza, et al.
Gynecologic Oncology|May 17, 2024
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparibJoyce F Liu, Niya Xiong, Robert M Wenham, et al.
Pageof 104